The Complete Genome offers a comprehensive analysis of an individual’s entire DNA. Unlike exome sequencing, which focuses only on the coding regions of genes, complete genome sequencing analyzes 100% of the genome, including exons, introns, regulatory regions, and structural variations.
Overview
There are over 6,000 rare diseases affecting more than 300 million people worldwide.
Studies by the Brazilian Society of Endocrinology and Metabolism show that 80% of rare diseases have a genetic origin, meaning they are inherited from biological parents.
When there is suspicion of genetic diseases caused by mutations in any part of the genome, including intronic, regulatory regions, and structural variants.
Rare or undiagnosed genetic diseases
When other tests, such as exome sequencing or smaller genetic panels, were inconclusive.
Patients with multisystemic diseases or clinical features suggesting a complex genetic origin
Family history of genetic diseases
For individuals or families with multiple generations affected by a genetic condition without a clearly identified cause.
Genes Analyzed
The test sequences the entire human genome, which includes approximately 20,000 genes and about 3 billion base pairs of DNA. It encompasses not only coding regions of genes (exons) but also intronic (non-coding) regions, promoter regions, and other regulatory areas, as well as structural variants (such as CNVs and genomic rearrangements).